Frontiers in glomerulonephritis is organized by Royal Society of Medicine - Clinical neurosciences section and would be held on Nov 9, 2016 at Royal Society Of Medicine, London, England, United Kingdom. The target audience for this medical event basically for Nephrologists.
The aim of the meeting is to review advances in clinical trials, therapeutic regimes and pathogenesis of glomerular disease. Updates include newer therapies in vasculitis, the evolving story of membranous nephropathy and novel insight to complement disorders. This CME conference has been approved with 6 CPD points.
Conference Objectives :
• Clinical trials in glomerulonephritis
• Review of therapeutic agents and immunosuppressant regimens
• Novel insights on renal biopsy in glomerular disease
• HUS and C3 nephropathy – a review of complement disorders in the glomerulus
• Lupus nephritis and steroid sparing therapy
• Therapeutic advances in vasculitis
• Outcomes from the VALIGA Study Group in IgA nephropathy
• B-cell depletion in minimal change and FSGS